Galectin-9 expression is frequently altered in cancer and involved in several aspects of tumor progression [15,16,17,18], making galactin-9 an interesting potential prognostic marker and a therapeutic target for several malignancies. This evidence concerns the gene LGALS9 and neoplasm.